Open Access

The addition of whole soy flour to cafeteria diet reduces metabolic risk markers in wistar rats

  • Gláucia Ferreira Andrade1,
  • Crislaine das Graças de Almeida1,
  • Ana Cristina Rocha Espeschit1,
  • Maria Inês de Souza Dantas1,
  • Laércio dos Anjos Benjamin2,
  • Sonia Machado Rocha Ribeiro1 and
  • Hércia Stampini Duarte Martino1Email author
Lipids in Health and Disease201312:145

https://doi.org/10.1186/1476-511X-12-145

Received: 15 August 2013

Accepted: 8 October 2013

Published: 11 October 2013

Abstract

Background

Soybean is termed a functional food because it contains bioactive compounds. However, its effects are not well known under unbalanced diet conditions. This work is aimed at evaluating the effect of adding whole soy flour to a cafeteria diet on intestinal histomorphometry, metabolic risk and toxicity markers in rats.

Methods

In this study, 30 male adult Wistar rats were used, distributed among three groups (n = 10): AIN-93 M diet, cafeteria diet (CAF) and cafeteria diet with soy flour (CAFS), for 56 days. The following parameters were measured: food intake; weight gain; serum concentrations of triglycerides, total cholesterol, HDL-c, glycated hemoglobin (HbA1c), aspartate (AST) and alanine (ALT) aminotransferases and Thiobarbituric Acid Reactive Substances (TBARS); humidity and lipid fecal content; weight and fat of the liver. The villous height, the crypt depth and the thickness of the duodenal and ileal circular and longitudinal muscle layers of the animals were also measured.

Results

There was a significant reduction in the food intake in the CAF group. The CAFS showed lower serum concentrations of triglycerides and serum TBARS and a lower percentage of hepatic fat, with a corresponding increase in thickness of the intestinal muscle layers. In the CAF group, an increase in the HbA1c, ALT, lipid excretion, liver TBARS and crypt depth, was observed associated with lower HDL-c and villous height. The addition of soy did not promote any change in these parameters.

Conclusions

The inclusion of whole soy flour in a high-fat diet may be helpful in reducing some markers of metabolic risk; however, more studies are required to clarify its effects on unbalanced diets.

Keywords

Soybean Cafeteria diet Functional foods Intestinal histomorphometry Lipid peroxidation

Resumo

Introdução

A soja é um alimento funcional por conter compostos bioativos. Entretanto, seu efeito não é bem conhecido em situações de desequilíbrio alimentar. Este trabalho objetivou avaliar o efeito da adição de farinha integral de soja em uma dieta de cafeteria sobre a histomorfometria intestinal, risco metabólico e marcadores de toxicidade em ratos.

Métodos

Trinta ratos machos adultos Wistar foram utilizados no estudo, os quais foram distribuídos em três grupos (n = 10): dieta AIN-93 M, dieta de cafeteria (CAF) e dieta de cafeteria com adição de farinha de soja (CAFS), por 56 dias. Foram mensurados o consumo alimentar, ganho de peso, concentrações séricas de triacilgliceróis, colesterol total, HDL-c, hemoglobina glicada, enzimas aspartato (AST) e alanina (ALT) aminotransferases e TBARS; umidade e conteúdo de lipídio das fezes; peso e gordura hepática. A altura de vilosidade, profundidade de cripta e espessura das camadas musculares circular e longitudinal do duodeno e íleo dos animais foram também mensurados.

Resultados

Houve redução significativa do consumo alimentar no grupo CAF. CAFS apresentou menores concentrações séricas de triacilgliceróis e TBARS e menor percentual de gordura hepática; e maior espessura das camadas musculares. No grupo CAF foi observado aumento da HbA1c, ALT, excreção lipídica, TBARS hepático e profundidade de cripta, associado a menor HDL-c e altura de vilosidade. A adição de farinha integral de soja não acarretou mudança desses parâmetros.

Conclusões

A inclusão de farinha integral de soja em uma dieta hiperlipídica pode auxiliar na redução de alguns marcadores de risco metabólico, entretanto, mais estudos são necessários para esclarecer seu efeito em dietas desbalanceadas.

Background

Obesity has become a major public health problem worldwide. It is followed by a significantly higher risk of developing chronic diseases such as type 2 diabetes, hypertension, dyslipidemia and atherosclerosis. The prevalence of these diseases, commonly related to Metabolic Syndrome, has overtaken malnutrition and infectious diseases, contributing to morbidity, across the world [1]. The rapid increase in obesity is found to be linked more to lifestyle changes in the population, produced by the consumption of hypercaloric diets, rich in fats and simple sugars, and a sedentary lifestyle, than to genetic factors [2]. The cafeteria diet is an experimental model used to study the effects of Western dietary pattern on animal health, because it is able to represent the food intake of modern societies, characterized by meals prepared at cafeterias and Fast Foods joints [3, 4]. The cafeteria diet is a robust experimental model of human metabolic syndrome, capable of inducing obesity, glucose intolerance and inflammation in rats [4].

Once the origin of obesity and metabolic disorders is established, often the correct diet and nutrition may also form part of the solution, providing health benefits. Currently, the interest evinced by the population for dietary interventions to control excess body weight, dyslipidemia and hyperglycemia has increased. Soy has been widely studied because it contains vegetable protein of high biological value, bioactive peptides, polyunsaturated fatty acids and dietary fiber [5]. It also possesses phytochemicals, including isoflavones and phytate, which may contribute to the reduction of the risk factors of cardiovascular disease (CVD), type 2 diabetes mellitus and atherosclerosis [68]. However, it has been reported that soy, in addition to a balanced diet, changes the intestinal morphology, impairing the nutrient absorption in the small intestine [9, 10].

Several studies have shown that soy protein in its isolated or textured form has lipid-lowering properties, reducing the serum levels of total cholesterol, LDL cholesterol, VLDL and triglycerides, and decreasing the susceptibility of lipoproteins to oxidation, which represents a risk factor related to the early development of atherosclerosis. The mechanisms that promote the lipid-lowering effect of soy protein have not yet been fully understood; however, they may be related to the inhibition of dietary cholesterol absorption, enhanced excretion of bile acids and an increased number of tissue activity receptors of LDL-c [7, 1113].

Some evidences of the direct action of the peptide or protein, rather than the other chemical components present in soybean were revealed [14, 15]. Others showed that the cholesterol-lowering effect of soy protein was associated with the presence of isoflavones [7, 16], which also reveal an antioxidant action, helping to reduce the lipid peroxidation [1720].

Therefore, the effects of soy protein and isoflavones have been isolated, investigated or linked together, which often do not reveal the reality of the full consumption of the soy, because the soy also contains soy fiber and polyunsaturated fatty acids, phytates, protease inhibitors, lipoxygenase and oligosaccharides, which have both functional and antinutritional properties.

The soybean cultivar UFVTN 105AP for human consumption offers high protein concentration and in order to improve the nutritional and sensory characteristics of soybean is free of lipoxygenase [21]. The development of the soybean culture is accompanied by the need to evaluate the beneficial or adverse effects of the soy on the body, associated with a cafeteria diet, the main characteristic of modern lifestyle.

The objective of this work was to evaluate the effect of adding soy flour to the cafeteria diet on the lipid and carbohydrate metabolism, lipid peroxidation, in the serum concentration of the enzymes alanine aminotransferase and aspartate, and in the intestinal and liver histomorphometry of adult Wistar rats.

Results

The weight gained by the animals did not differ between the groups; however, the total food consumption of the animals was lower (p < 0.05) in the groups fed on the cafeteria diet, CAF (+) and CAFS compared with the negative control group, AIN-93 M (-). The animals in the CAF (+) and CAFS groups reduced their food intake without any alteration in weight gain. This fact promoted the increase (p < 0.05) of Feed Efficiency Ratio (FER) (Table 1). The serum levels of the total cholesterol and the total HDL-c/cholesterol ratio did not differ (p ≥ 0.05) among the experimental groups. The serum triglyceride levels did not differ between the groups CAF controls (+) and AIN-93 M (-), although they were lower (p <0.05) in CAFS. The CAF (+) and CAFS diets reduced the serum HDL-c (p < 0.05) and increased the serum concentration of the glycated hemoglobin (p < 0.05) compared with the group AIN-93 M (-). The animals in the CAF (+) and CAFS groups excreted greater amounts of lipids (p < 0.05) in the feces compared with those fed with on the AIN-93 M (-) diet (Table 1).
Table 1

Metabolic parameters of animals treated with different diets after 56 days of experiment

Parameters*

Experimental groups

AIN – 93 M

CAF

CAFS

Weigth gain (g)

151.00a ± 31.75

170.40a ± 53.80

162.10a ± 29.98

DI (g)

1786.56a ± 45.46

1402.94b ± 51.61

1415.46b ± 77.24

FER

0.08a ± 0.017

0.11b ± 0.033

0.114b ± 0.020

Energy intake (Kcal/dia)

81.34

94.73

96.31

Triglycerides (mg/dL)

215.22 a ± 40.74

215.10a ± 47.07

163.32b ± 58.18

Total cholesterol (mg/dL)

128.21a ± 24.48

105.13a ± 10.97

115.65a ± 22.77

HDL (mg/dL)

47.43a ± 8.35

38.18b ± 6.74

37.87b ± 7.20

HDL/total cholesterol

0.37a ± 0.05

0.35a ± 0.05

0.33a ± 0.07

HbA1c (%)

9.49a ± 2.58

16.53b ± 5.98

15.69b ± 7.48

Fecal humidty (%)

27.96a ± 7.22

22.09b ± 7.98

24.11ab ± 3.68

Fecal lipid (%)

3.10a ± 0.55

13.29b ± 1.56

13.65 b ± 1.39

Liver weight (g)

15.95a ± 2.36

16.58a ± 2.18

15.44a ± 2.13

HIS

3.45a ± 0.35

3.44a ± 0.37

3.24a ± 0.21

Liver fat (%)

0.61a (0.06-10.54)

0.07a (0.01-15.29)

0.17b (0.01-3.84)

ALT (UI/L)

90.03a ± 12.00

130.76b ± 22.03

127.85b ± 25.33

AST (UI/L)

338.59a ± 87.93

380.11a ± 113.07

422.35a ± 163.13

Results are expressed as mean ± SD for all parameters with exception of liver fat witch is represented by median (maximum and minimum). AIN-93 M diet: negative control group (n = 10/group); cafeteria diet (CAF): positive control group (n = 10/group); and caferia diet with whole soybean flour (CAFS) (n = 10/group). To compare the experimental groups with exception of LH Duncan test was used. To compare LF parameter between experimental groups Kruskall-Wallis test was used. For each evaluated characteristic means followed by the same letter in the lines are not significantly different at 5% probability.

*ALT, enzyme alanine aminotransferase; AST, enzyme aspartate aminotransferase; DI, dietary intake; FER, feed efficiency ratio; HbA1c, glycated hemoglobin; HDL, high density lipoprotein; HIS, hepatosomatic index.

The hepatosomatic index did not differ (p > 0.05) among the experimental groups. But it was observed that the CAFS group has less accumulated fat in the liver (p < 0.05) (Table 2). The serum levels of the enzyme aspartate aminotransferase did not differ (p ≥ 0.05) among the experimental groups, although an increase in the serum concentrations of the enzyme alanine aminotransferase (p < 0.05) was observed with CAF (+) and CAFS (Table 1).

The serum TBARS levels were lower (p < 0.05) with CAF (+) than with other diets. However, the TBARS in the liver and testicles were higher (p < 0.05) with CAF (+) and the CAFS diet compared with the AIN-93 M (-). The CAFS diet increased the TBARS concentration in the lung (p < 0.05). However, in the kidney, the concentration of the TBARS was found to be significantly higher (p < 0.05) in the CAF (+) group (Table 2).

Table 2

TBARS* concentrations in different organs of animals fed with experimental diets

Organs

Experimental groups

AIN 93-M

CAF

CAFS

Serum

1.64a ± 0.47

1.23b ± 0.23

1.74a ± 0.16

Liver

0.09b ± 0.03

0.40a ± 0.10

0.44a ± 0.152

Lung

77.43b ± 14.00

76.54b ± 45.28

235.46a ± 77.99

Testicle

10.13b ± 3.69

17.94a ± 9.50

18.07a ± 7.82

Kidney

92.30b ± 15.59

120.07a ± 25.64

97.82b ± 19.13

Results are expressed as mean ± SD. AIN-93 M diet. Negative control group (n = 10/group); cafeteria diet (CAF), positive control group (n = 10/group); and caferia diet with whole soybean flour (CAFS) (n = 10/group). To compare the experimental groups Duncan test was used. For each evaluated characteristic means followed by the same letter in the lines are not significantly different at 5% probability.

*TBARS, test thiobarbituric acid reactive substances.

The animals in the CAF (+) and CAFS groups showed a reduction in villous height (p <0.05) and an increase in the duodenal crypt depth (p < 0.05). The thicknesses of the circular and longitudinal muscles was greater (p < 0.05) in the CAFS group (Table 3). In the ileal portion of the small intestine the villous height decreased (p < 0.05) in those rats on the CAFS diet compared with the negative control (AIN-93 M) and increased (p < 0.05) compared with the positive control, CAF. The measurements of crypt depth and layer thickness of the longitudinal muscle were greater (p <0.05) in the CAFS group. The thickness of the circular muscle layer in the CAF (+) and CAFS groups was similar (p > 0.05), but higher (p < 0.05) when compared with the negative control, AIN-93 M (Table 3).
Table 3

Measurements (mm) of duodenum and ileum of animals

Portion of small intestine

Parameters*

Experimental groups

AIN-93 M

CAF

CAFS

Duodenum

VH

157.1a ± 22.4

123.4b ± 33.4

130.2b ± 18.5

CD

223.6b ± 24.2

258.1a ± 47.7

262.6a ± 34.2

TLML

63.0b ± 19.2

63.1b ± 18.7

89.9a ± 30.4

TCML

88.1b ± 32.4

79.0b ± 17.5

108.0a ± 31.4

Ileum

VH

598.2a ± 80.8

426.5c ± 122.1

503.9b ± 79.9

CD

235.6b ± 35.7

243.3b ± 42.8

272.9a ± 58.2

TLML

69.9b ± 16.8

76.8b ± 11.5

87.9a ± 15.0

TCML

50.8b ± 12.6

57.4a ± 12.2

59.1a ± 22.8

Results are expressed as mean ± SD. AIN-93 M diet: negative control group (n = 10/group); cafeteria diet (CAF): positive control group (n = 10/group); and cafeteria diet with whole soybean flour (CAFS) (n = 10/group). To compare the experimental groups Duncan test was used. For each evaluated characteristic means followed by the same letter in the lines are not significantly different at 5% probability.

*CD, crypt depth; TCML, thicknesses of the circular muscle layer; TLML, thicknesses of the longitudinal muscle layer; VH, villus height.

Discussion

The cafeteria diets, with or without the addition of whole soy flour, despite being hyperlipidemic and hypercaloric, did not affect weight gain in the animals. Therefore, weight gain is an indirect parameter to the evaluated inflammatory state. It is known that the cafeteria diet is considered a robust model of the human metabolic syndrome with reference to the liver and adipose tissues [4]. There is evidence that the diet-induced metabolic dysfunctions observed in the rats are independent of the degree of increase in total body weight [22]. The low food intake in the CAF group was probably due to their higher energy density. It is known that rats tend to maintain their energy intake at a relatively fixed rate [23, 24]. This result is in accordance with the higher FER in the CAF and CAFS groups. Rats from the CAF group required less food intake to gain one gram of weight. As CAFS do not differ from the CAF, it could be that the fiber content was insufficient to reduce the food intake.

The serum concentrations of total cholesterol, triglycerides and hepatic fat content were not changed with the consumption of the CAF diet. These changes might have occurred because the rats increased the excretion of fecal lipids, by approximately four times. The addition of whole soy flour in the CAF group did not change these parameters; however, it decreased (p < 0.05) the serum triglycerides. This effect of whole soy flour of lowering the triglyceride level can be attributed to the soy protein and or the presence of isoflavones and dietary fiber [18, 25]. The hypotriglyceride property of soybean was observed in other studies as well, with animals and humans on balanced diets [2529]. It was interesting to note that whole soy flour in the cafeteria diet decreased the liver fat (p < 0.05), countering the effect of the high-fat diet. This fact shows the biologic protective effect of soy flour in response to metabolic syndrome, as an effective prevention of non-alcoholic fatty liver disease (NFLD). It was observed that the CAF diet increased the serum alanine aminotransferase enzyme (ALT) levels in the liver of the animals. This concurs with the results of MacQueen et al. [30], in animals treated with the cafeteria diet. The liver injury could have been caused by steatosis, a disease state characterized by inflammation, fibrosis, cell death and insulin resistance [31]. The addition of whole soy flour to the cafeteria diet did not result in the ALT concentration returning to levels similar to those of the negative control, although it decreased the hepatic fat.

A reduction in the serum HDL-C concentration was noted in the group receiving the cafeteria diet, positive control, similar to that the results found by MacQueen et al. [30], in Sprague Dawley rats. Due to the high HDL-c levels acting as a protective factor against possible cardiovascular events [32], the cafeteria diet had adverse health effects, which were not attenuated by the presence of the soy flour.

The animals treated with the high-fat diet cafeteria CAF showed an increase in the HbA1c. This kind of diet can affect the insulin-mediated glucose metabolism [30, 33, 34], by decreasing the glucose transporter 4 expression [35], changing via insulin-signaling [36] in the muscle and adipose tissues. Despite being reported in the literature that soy consumption has a positive effect on the glucose metabolism [18], this relationship was not observed in the present study when whole soy flour was added to an unbalanced diet. The whole soy flour was the intake at the dietetic level by the rats, and later it could have been difficult to counter the effect of the high-fat diet.

The CAF diet decreased the serum lipid peroxidation. It is likely that the animals treated with the cafeteria diet have higher circulating levels of free saturated fatty acids. It is known that the saturated fatty acids are more resistant to peroxidation than the unsaturated fatty acids, in rats on the AIN-93 M (-) diet [32, 37]. Also, soybean flour has a high concentration of polyunsaturated fatty acids [5] which can undergo peroxidation. Therefore, when whole soy flour was added to the CAF diet, it increased the lipid peroxidation to the same level (p > 0.05) as the negative control, returning at physiological levels. This can be attributed to the antioxidant compounds present in soy flour, such as isoflavones [3840] and vitamin E [41], which may protect it against lipid peroxidation [42].

In the tissues, the CAF diet increased the lipid peroxidation in the liver, testicles and kidney. When whole soy flour was added to the CAF diet, this parameter did not change (p > 0.05) either in the liver or testicles, although it decreased in the kidney (p < 0.05). This fact demonstrated that bioactive compounds have different bio-accessibility in the biological tissues. In the lung, the CAFS diet showed lipid peroxidation approximately three times higher than the CAF and AIN-93 M (-) diets. Bioactive compounds of whole soy flour can perform the redox cycle with oxygen and become pro-oxidant in the lung, which has a high oxygen concentration. There are strong suggestions that dietary antioxidant can induce reactive oxygen species and thereby trigger an adaptive stress response and hormesis, and as a result the cells will increase their production of cytoprotection against oxidative stress [43].

Regarding intestinal morphology, it was observed that the cafeteria diet reduced the villous height and increased the crypt depth of the duodenum, which could adversely impair nutrient absorption. However, these results differ from those obtained by Scoaris et al. [2], who demonstrated an increase in the villous height and crypt depth of the jejunum of the rats fed on the cafeteria diet. The CAF diet effect is expected, because of its inflammatory potential, which has been reported in the literature [44], to significantly compromise the integrity of the intestinal mucosa as a whole. However, the relationship between a high-fat diet, imbalanced gut microbiota and the host pathophysiology remains to be elucidated. It was discovered that bile acid, the main component of bile, is a host factor that regulates the composition of the cecal microbiota in rats. It is because bile secretion increases on the high-fat diet, and bile acids generally exhibit strong antimicrobial activity, it was speculated that the bile acids would be a determinant of the gut microbiota in response to a high-fat diet [45]. The changes observed in the rat cecal microbiota triggered by the administration of cholic acid (the most abundant bile acid in human biliary bile) resemble those found in the animals fed on high-fat diets.

The effect of adding whole soy flour to the CAF diet caused no change in the villi and crypts, but increased the thicknesses of the circular and longitudinal muscle layers. Then, soybean contributed to the increase in the intestinal muscle layers, which led to greater intestinal peristalsis. Perhaps, because of the presence of the soluble fiber and soy oligosaccharides, besides the allergenic factors, such as protein fractions glycinin and β-conglycinin, the addition of the soy flour to the cafeteria diet could not reverse the malefic effect of the cafeteria diet on the duodenal villi [4648]. Another component of the soybean that could exert a negative effect on the small intestine is lectin. However, in this study, the lectin had not compromised the intestinal parameters in the soybean meal diet due to the heat treatment applied to the soybean (150 °C/30 min) when preparing the meal. According to Machado et al. [49], the thermal treatments in the autoclave at 120°C for 5, 10, 15 and 25 minutes were effective in inactivating the protease inhibitors and lectins.

However, the presence of the soy flour contributed to a lower degree of villous atrophy in the ileum in relation to the cafeteria diet group, positive control, and a greater crypt depth when compared with the other groups. The villous atrophy is caused by increased cell loss by desquamation or by the lowered cell renewal process. The villous atrophy that occurs via increased cell loss is associated with the increased production of cells in the crypt, and therefore, an increase in crypt depth [50], as observed in the duodenum and ileum of animals fed on the cafeteria diet containing whole soybean flour.

Conclusion

The present study reports that the addition of soy flour was beneficial, considering that there was a reduction in the serum triglycerides, the percentage of fat in the liver regions and an increased thickness of the intestinal muscle layers, improving gut peristalsis. However, the incorporation of a functional food such as soy in the cafeteria diet was insufficient to undo the harmful effects that this type of diet causes to health.

Methods

Soybean flour

The cultivar UFVTN 105AP for human consumption was provided by the Institute of Biotechnology Applied to Livestock (BIOAGRO), Federal University of Viçosa, Viçosa, MG, Brazil. It is a cultivar developed without LOX1, LOX2 and LOX3 lipoxygenases, called triple null, with a high protein content [21]. To prepare the whole soybean flour, soybeans were selected and subjected to the process of flushing with water and dried at an ambient temperature. They were then subjected to 150°C temperature for 30 minutes in a stove with air circulation, chilled and stored in polyethylene bags. The grains along with the shells were milled in knife mills and passed through a sieve of 60 (0.25 mm) mesh [21].

Experimental animals

A total of 30 male rats were used (Rattus norvegicus albinos, Mammalia, Wistar lineage), from the Central Biotherium of the Center for Biological Sciences and Health, Federal University of Viçosa. The animals were purchased early, weaned and maintained in individual cages in an acclimatized environment, receiving commercial chow until they reach the adult stage (10 weeks old, ~ 300 g).

During the experimental phase, the animals were maintained in individual cages in a temperature-controlled environment of 22 ± 2°C, 12 h photoperiod, receiving their daily diet and distilled water ad libitum. They were divided into three groups of 10 animals each, and given experimental diets for a period of 56 days, as shown in Table 4.
Table 4

Experimental diets composition (g/100 g)

Ingredients

AIN 93-M

CAF

CAFS

Case in (% protein)

15.40

0

0

Saccharose

10.00

0

0

Corn starch

43.92

0

0

Dextrinized starch

15.50

0

0

Soybean oil

5.25

0

0

Microcrystalline cellulose

5.00

0

0

Mineral mix AIN93M

3.50

0

0

Vitamin mix AIN93M

1.00

0

0

L-cystine

0.18

0

0

Choline bitartrate

0.25

0

0

Whole soybean flour

0

0

27.67

Chicken liver patê

0

14.28

10.33

Sweet biscuit (Aymore®)

0

14.28

10.33

Potato Chips (Quezinha®)

0

14.28

10.33

Chocolate (Garoto®)

0

14.28

10.33

Bacon

0

14.28

10.33

Commercial chow

0

28.57

20.67

Results are expressed as mean. AIN-93 M diet, negative control group (n = 10/group); cafeteria diet (CAF), positive control group (n = 10/group); and cafeteria diet with whole soybean flour (CAFS) (n = 10/group).

Experimental design

A 56-day controlled experimental study was conducted, for parameter analysis in vivo and ex vivo. The effects of the soy flour intake to modulate the metabolic and morphological parameters of the animals were evaluated in all three groups of animals who received the following diet pellets: i) AIN-93 M (-) [51], considered the negative control, ii) CAF (+): positive control cafeteria diet, iii) CAFS: cafeteria diet + 27.67 g of whole soy flour, which is equivalent to the amount of protein provided by AIN-93 M diet, negative control.

The cafeteria diet consisted of chicken liver pate, sweet biscuit, potato chips, milk chocolate, bacon and commercial chow in the ratio of 1:1:1:1:1:2 [3]. The caloric density of the AIN-93 M, CAF and CAFS diets was 2.54 kcal/g, 4.23 kcal/g and 4.09 kcal/g, respectively; whereas the percentage contribution of the macronutrients in the energy content of the AIN-93 M, CAF and CAFS diets were, 7.9, 58.5 and 54.2%, respectively, of energy as fat, 14.9, 12.9 and 20.7%, respectively, as protein, and 77.1, 28.6 and 25.1%, respectively, as carbohydrate. The CAF and CAFS diets were hypercaloric and hyperlipidic compared with the AIN-93 M diet (Table 5).
Table 5

Moisture, protein, fat, carbohydrate, ash, dietary fiber and energy density from the diets

Nutritional values

AIN-93 M

CAF

CAFS

Moisture (%)

32.20a ± 0.08

23.25b ± 0.45

19.80c ± 0.02

Protein (g/100 g)

9.52c ± 0.52

13.52b ± 0.74

21.28a ± 0.05

Fat (g/100 g)

2.25c ± 0.65

27.19a ± 0.28

24.74b ± 0.07

Carbohydrate (g/100 g)

49.15a ± 1.16

29.88b ± 0.74

25.82c ± 0.06

Ash (g/100 g)

1.87c ± 0.02

3.13b ± 0.14

3.67a ± 0.07

Dietary Fiber (g/100 g)

5.00a ± 0.13

3.02c ± 0.03

4.69b ± 0.02

Energy density (kcal/g)

2.55c ± 0.03

4.18a ± 0.01

4.11b ± 0.01

Results are expressed as mean ± SD. AIN-93 M diet: negative control group (n = 10/group); cafeteria diet (CAF): positive control group (n = 10/group); and caferia diet with whole soybean flour (CAFS) (n = 10/group). To compare the experimental groups Tukey test was used. For each evaluated characteristic means followed by the same letter in the line are not significantly different at 5% probability.

The dietary intake was evaluated by recording the daily food intake, and weight gain was obtained from the difference between the initial and final weights of the animals. The Feed Efficiency Ratio (FER) was determined from the ratio of the weight gain of the animal and the consumption of the experimental diet.

At the end of the experiment, the animals were fasted for 12 hours, anesthetized with ether and subjected to euthanasia by exsanguination. Their blood was collected and centrifuged at 1000 × g for 15 minutes to obtain the serum that was stored at -20°C, for biochemical serum samples, and -80°C for peroxidation analysis. The following organs were removed: the liver, proximal (duodenum) and distal (ileum) small intestine, kidney, lung and testicles. The liver, kidney, lung and testicles were kept in liquid nitrogen and lyophilized for subsequent biochemical analyses. Samples of the liver and portions of the small intestine, duodenum and ileum were fixed in Bouin's fluid for histological studies.

The feces were collected during the last week of the experiment and were subjected to drying and grinding for determination of the water and lipid content, according to the methodology of AOAC [52].

It must be mentioned that this experiment was approved by the Ethics Committee on Animal Research of the Federal University of Minas Gerais (UFMG-CETEA), Case 212/2009, and was conducted in accordance with the Ethical Principles of Animal Experimentation (CETEA / UFMG).

Serum parameters

The total cholesterol, HDL fraction and triglycerides were determined using the enzymatic colorimetric method; glycated hemoglobin (Hb1Ac) was determined by the ion exchange method; while the activity of the aminotransferases was checked using the UV kinetic method. All analyses were performed using the commercial kits (Human do Brasil®), in accordance with manufacturer guidelines.

Lipid peroxidation analysis

Lipid peroxidation was estimated in the serum and tissue homogenates of the lyophilized liver, lung, kidney and testicles through the Thiobarbituric Acid Reactive Substances (TBARS) test, according to the methodology described by Buege and Aust [53]. In order to obtain the homogenates, tissue lyophilisates were resuspended in a 0.1 M phosphate buffer, pH 7.4, at 1:10 (m / v).

Hepatosomatic index (HSI)

After excision, the animal's liver weights were registered and used to calculate the hepatosomatic index, which represented the relationship between the organ weight and the weight of the live animal, after undergoing a 12-hour fast.

Histological analysis

The fragments of the liver, duodenum and ileum were collected from six animals in each experimental group. The intestine and liver portions were fixed in Bouin's fluid for a minimum of 24 hours and preserved in 70% alcohol. Nine semi-serial transversal sections, 3 μm in thickness, using hematoxylin/eosin stain were obtained from the duodenum, ileum and liver. The slides were analyzed under the light microscope Olympus CX31, and the images were obtained with a digital camera SC 020, through the GetIt Analysis software, Olympus. In order to measure the villous height, crypt depth and thickness of the internal and external muscle layers, we used the Image-Pro Plus® version 4.5 software. The images captured were utilized for visualization and quantification of the fat regions of the liver tissue; the morphometry of the circular and longitudinal muscle layers of the intestine was done by using the 10× objective, whereas the morphometry of the villi and crypts in the duodenum and the ileum was used visualized using a 4× lens.

The fat deposition in the liver was determined using the computational quantification of fat droplets and the values were obtained by applying the algorithm developed programming language Open Source SciLab, version 4.1 (INRIA, ENPC, 2006), utilizing the principle of thresholding (Figure 1) [54].
Figure 1

Photomicrography of the liver of animals fed with cafeteria diet. Bar: 3 μm. Hematoxylin-Eosin staining.

In the two portions of the intestine, the measurements of villous height, crypt depth and the thickness of the circular and longitudinal muscle layers were obtained using the Image Pro-Plus® version 4.5 software (Media Cybernetics) [55] (Figure 2). To take these measurements, 10 random fields were selected per animal, totaling to 40 measurements for each parameter analyzed.
Figure 2

Graphical representation of the measurements in the intestine of animals. 2a: 40×; 2b: 100×.

Estatistical analysis

The experimental design was in blocks, with three treatments and ten replications. In order to proceed with the histological analysis of the intestine, four replications were used. The data of weight gain, feed intake, biochemical parameters, water, lipid and fecal contents, hepatosomatic index, lipid peroxidation and intestinal histomorphometry were analyzed using ANOVA and the results expressed as mean ± standard deviation. Significant differences between the groups were detected by the Duncan test, using the Statistical Analysis Software System for (SAEG) version 9.1 [56], licensed by the Federal University of Viçosa. The Kruskal-Wallis test was used to analyze the hepatic fat deposition, using the Sigma STAT software version 2.03. The level of significance was set at 5%.

Abbreviations

ALT: 

Enzyme alanine aminotransferase

AST: 

Enzyme aspartate aminotransferase

CAF: 

Cafeteria diet

CAFS: 

Cafeteria diet with soy flour

CD: 

Crypt depth

CVD: 

Cardiovascular disease

DI: 

Dietary intake

FER: 

Feed efficiency ratio

HbA1c: 

Glycated hemoglobin

HIS: 

Hepatosomatic index

TBARS: 

Test thiobarbituric acid reactive substances

TCML: 

Thicknesses of the circular muscle layer

TLML: 

Thicknesses of the longitudinal muscle layer

VH: 

Villous height

VLDL: 

Very low density lipoprotein.

Declarations

Acknowledgements

To the Institute of Applied Biotechnology for Agriculture (BIOAGRO) for providing the soybean cultivar. To Paulo Burlamaqui, for his contribution in the histological analyses.

Source of funding

The Foundations for Research Support of the State of Minas Gerais (FAPEMIG) and Coordination of Improvement of Higher Education Personnel (CAPES), Brazil, by research support, the payment of the article charge and the scholarship.

Authors’ Affiliations

(1)
Department of Nutrition and Health, CCB-II, Federal University of Viçosa
(2)
Department of Veterinary Medicine, Federal University of Viçosa

References

  1. Spijker JJA, Ca’mara AH, Blanes A: The health transition and biological living standards: adult height and mortality in 20th-century Spain. Econ Hum Biol. 2012, 10 (3): 276-288. 10.1016/j.ehb.2011.08.001View ArticlePubMedGoogle Scholar
  2. Scoaris CR, Rizo GV, Roldi LP, de Moraes SM, de Proença AR, Peralta RM, Natali MR: Effects of cafeteria diet on the jejunum in sedentary and physically trained rats. Nutrition. 2010, 26 (3): 312-320. 10.1016/j.nut.2009.04.012View ArticlePubMedGoogle Scholar
  3. Campión J, Martinez JA: Ketoconazole, an antifungal agent, protects against adiposity induced by a cafeteria diet. Horm Metab Res. 2004, 36 (7): 485-491. 10.1055/s-2004-825729View ArticlePubMedGoogle Scholar
  4. Sampey BP, Vanhoose AM, Winfield HM, Freemerman AJ, Muehlbauer MJ, Fueger PT, Newgard CB, Makowski L: Cafeteria diet is a robust model of human metabolic syndrome with liver and adipose inflammation: comparison to high-fat diet. Obesity. 2011, 19 (6): 1109-1117. 10.1038/oby.2011.18PubMed CentralView ArticlePubMedGoogle Scholar
  5. Esteves EA, Martino HSD, Oliveira FCE, Bressan J, Costa NMB: Chemical composition of a soybean cultivar lacking lipoxygenases (lox2 and lox3). Food Chem. 2010, 122 (1): 238-242. 10.1016/j.foodchem.2010.02.069. 10.1016/j.foodchem.2010.02.069View ArticleGoogle Scholar
  6. Esteves EA, Bressan J, Costa NM, Martino HS, Donkin SS, Story JA: Modified soybean affects cholesterol metabolism in rats similarly to a commercial cultivar. J Med Food. 2011, 14 (11): 1363-1369. 10.1089/jmf.2010.0160View ArticlePubMedGoogle Scholar
  7. Wilson AW, Nicolosi RJ, Kotyla T, Fleckinger B: Soy protein without isoflavonas reduces aortic total and cholesterol ester concentrations. Nutr Res. 2007, 27: 498-504. 10.1016/j.nutres.2007.05.005. 10.1016/j.nutres.2007.05.005View ArticleGoogle Scholar
  8. Xiao CW: Health effects of Soy protein and isoflavones in humans. J Nutr. 2008, 138 (6): 1244S-9S.PubMedGoogle Scholar
  9. Schönhusen U, Kuhla S, Rudolph PE, Zitnan R, Albrecht D, Huber K, Voigt J, Flöter A, Hammon HM, Metges CC: Alterations in the jejunum of young goats caused by feeding soy protein-based diets. J Anim Physiol Anim Nutr. 2010, 94 (1): 1-14. 10.1111/j.1439-0396.2008.00873.x. 10.1111/j.1439-0396.2008.00873.xView ArticleGoogle Scholar
  10. Battistelli S, Citterio B, Baldelli B, Parlani C, Malatesta M: Histochemical and morpho-metrical study of mouse intestine epithelium after a long term diet containing genetically modified soybean. Eur J Histochem. 2010, 54 (3): 154-157.View ArticleGoogle Scholar
  11. Chagas CMA, Abdalla DSP, Lima Verde SMM, Damasceno NRT: Influência do isolado protéico da soja e da caseína sobre a peroxidação lipídica. Alim e Nutr. 2006, 17 (3): 309-316.Google Scholar
  12. Wang Y, Jones PJH, Ausman LM, Lichtenstein AH: Soy protein reduces triglyceride levels and triglyceride fatty acid fractional synthesis rate in hypercholesterolemic subjects. J Atherosclerosis. 2004, 173 (2): 269-275. 10.1016/j.atherosclerosis.2003.12.015. 10.1016/j.atherosclerosis.2003.12.015View ArticleGoogle Scholar
  13. Sirtori CR, Galli C, Anderson JW, Arnold A: Nutritional and nutraceutical approaches to dyslipidemia and atherosclerosis prevention: focus on dietary proteins. Atherosclerosis. 2009, 203 (1): 8-17. 10.1016/j.atherosclerosis.2008.06.019View ArticlePubMedGoogle Scholar
  14. Fukuy K, Kojima M, Tachibana N, Kohno M, Takamatsu K, Hirotsuka M, Kito M: Effects of soybean β-conglycinin on hepatic lipid metabolism and fecal lipid excretion in normal adult rats. Biosci Biotechn Biochem. 2004, 68 (5): 1153-1155. 10.1271/bbb.68.1153. 10.1271/bbb.68.1153View ArticleGoogle Scholar
  15. Sacks FM, Lichtenstein A, Horn LV, Harris W, Kris-Etherton P, Winston M: Soy protein, isoflavones, and cardiovascular health: a summary of a statement for professionals from the American heart association nutrition committee. Arterioscler Thromb Vasc Biol. 2006, 26: 1689-1692. 10.1161/01.ATV.0000227471.00284.efView ArticlePubMedGoogle Scholar
  16. Demonty I, Lamarche B, Deshaies Y, Jacques H: Role of soy isoflavonas in the hypotriglyceridemic effect of soy protein in the rat. J Nutr Biochem. 2002, 13 (11): 671-677. 10.1016/S0955-2863(02)00214-0View ArticlePubMedGoogle Scholar
  17. Heneman KM, Chang HC, Prior RL, Steinberg FM: Soy protein with and without isoflavones fails to substantially increase postprandial antioxidant capacity. J Nutr Biochem. 2007, 18 (1): 46-53. 10.1016/j.jnutbio.2006.03.001View ArticlePubMedGoogle Scholar
  18. Cederroth CR, Nef S: Soy, phytoestrogens and metabolism: a review. Mol Cell Endocrinol. 2009, 304: 30-42. 10.1016/j.mce.2009.02.027View ArticlePubMedGoogle Scholar
  19. Nagajan S: Mechanisms of anti-atherosclerotic functions of soy-based diets. J Nutr Biochem. 2010, 21 (4): 255-260. 10.1016/j.jnutbio.2009.09.002View ArticleGoogle Scholar
  20. Oliveira TT, Silva RR, Dornas WCA, Nagem TJ: Flavonóides e aterosclerose. Rev Bras Anal Clin. 2010, 42 (1): 49-54.Google Scholar
  21. Martino HSD, Carvalho AW, Silva CO, Dantas MIS, Natal DIG, Ribeiro SMR, Costa NMB: The use hull soybean flour of heat-treated grains does not affect iron bioavailability in rats. ALAN. 2011, 61 (2): 135-142.Google Scholar
  22. Naderali EK, Pickavance LC, Wilding JPH, Williams G: Diet-induced endothelial dysfunction in the rat is independent of the degree of increase in total body weight. Clin Sci. 2001, 100: 635-641. 10.1042/CS20000279View ArticlePubMedGoogle Scholar
  23. Adolph EF: Urges to eat and drink in rats. Amer J Physiol. 1947, 151: 110-125.PubMedGoogle Scholar
  24. Peterson AD, Baumgardt BR: Food and energy intake of rats Fed diets varying in energy concentration and density. J Nutrition. 1971, 101: 1057-1068.Google Scholar
  25. Torres N, Torre-Villalvazo I, Tovar AR: Regulation of lipid metabolism by soy protein and its implication in diseases mediated by lipid disorders. J Nutr Biochem. 2006, 17 (6): 365-373. 10.1016/j.jnutbio.2005.11.005View ArticlePubMedGoogle Scholar
  26. Zhan S, Ho SC: Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr. 2005, 81: 397-408.PubMedGoogle Scholar
  27. Deleprane JB, Chagas MA, Vellarde GC, Ramos CF, Boaventura GT: The impact of Non- and genetically modified soybean diets in aorta wall remodeling. Food Sci. 2010, 75 (7): T126-131. 10.1111/j.1750-3841.2010.01773.x. 10.1111/j.1750-3841.2010.01773.xView ArticleGoogle Scholar
  28. Inoue N, Nagao K, Sakata K, Yamano N, Gunawardena PER, Han S, Matsui T, Nakamori T, Furuta H, Takamatsu K, Yanagita T: Screening of soy protein-derived hypotriglyceridemic di-peptides in vitro and in vivo. Lip Health Dis. 2011, 10: 85-10.1186/1476-511X-10-85. 10.1186/1476-511X-10-85View ArticleGoogle Scholar
  29. Barrios-Ramos JP, Garduño-Siciliano L, Loredo M, Chamorro-Cevalos G, Jaramillo-Flores ME: The effect of cocoa, soy, oats and fish oil on metabolic syndrome in rats. J Sci Food Agric. 2012, 92: 2349-2357. 10.1002/jsfa.5637View ArticlePubMedGoogle Scholar
  30. MacQueen HA, Sadler DA, Moore SA, Daya S, Brown JY, Shuker DEG, Seaman M, Wassif WS: Deleterious effects of a cafeteria diet on the livers of nonobese rats. Nutr Res. 2007, 27 (1): 38-47. 10.1016/j.nutres.2006.10.003. 10.1016/j.nutres.2006.10.003View ArticleGoogle Scholar
  31. Garcia-Ruiz C, Baulies A, Mari M, Garcia-Roves PM, Fernandez-Chace JC: Mitochondrial dysfunction in nonalcoholic fatty liver disease and insulin resistance: cause or consequence?. Free Radic Res. 2013, 5: Epub ahead of print.Google Scholar
  32. Rael LT, Thomas GW, Craun ML, Curtis CG, Bar-Or R, Bar-Or D: Lipid peroxidation and the thiobarbituric acid assay: standardization of the assay when using saturated and unsaturated fatty acids. J Biochem Mol Biol. 2004, 37 (6): 749-752. 10.5483/BMBRep.2004.37.6.749View ArticlePubMedGoogle Scholar
  33. Folmer V, Soares JCM, Gabriel D, Rocha JBT: A high Fat diet inhibits δ-aminolevulinate dehydratase and increases lipid peroxidation in mice (Mus musculus). J Nutr. 2003, 133: 2165-2170.PubMedGoogle Scholar
  34. Hancock CR, Han D, Chen M, Terada S, Yasuda T, Wright DC, Holloszy JO: High-fat diets cause insulin resistance despite an increase in muscle mitochondria. PNAS. 2008, 105 (22): 7815-7820. 10.1073/pnas.0802057105PubMed CentralView ArticlePubMedGoogle Scholar
  35. Sevilla L, Gumà A, Enrique-Tarancón G, Mora S, Muñoz P, Palacín M, Testar X, Zorzano A: Chronic high-Fat feeding and middle-aging reduce in an additive fashion Glut4 expression in skeletal muscle and adipose tissue. Biochem Biophys Res Commun. 1997, 235: 89-93. 10.1006/bbrc.1997.6742View ArticlePubMedGoogle Scholar
  36. Zierath JR, Houseknecht KL, Gnudi L, Kahn BB: High-Fat feeding impairs insulin-stimulated GLUT4 recruitment via an early insulin-signaling defect. Diabetes. 1997, 46: 215-223. 10.2337/diab.46.2.215View ArticlePubMedGoogle Scholar
  37. Halliwell B, Chirico S: Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr. 1993, 57 (suppl): 715S-25S.PubMedGoogle Scholar
  38. Barnes S: The biochemistry, chemistry and physiology of the isoflavones in soybeans and their food products. Lymph Res Biol. 2010, 8 (1): 89-97. 10.1089/lrb.2009.0030. 10.1089/lrb.2009.0030View ArticleGoogle Scholar
  39. Patel RP, Boersma BJ, Crawford JH, Hogg N, Kirk M, Kalyanaraman B, Parks DA, Barnes S, Darley-Usmar V: Antioxidant mechanisms of isoflavones in lipid systems: paradoxical effects of peroxyl radical scavenging. Free Rad Biol Med. 2001, 31 (12): 1570-1581. 10.1016/S0891-5849(01)00737-7View ArticlePubMedGoogle Scholar
  40. Fritz KL, Seppanen CM, Kurzer MS, Csallany AS: The in vivo antioxidant activity of soybean isoflavones in human subjects. Nutrition Research. 2003, 23: 479-487. 10.1016/S0271-5317(03)00005-8. 10.1016/S0271-5317(03)00005-8View ArticleGoogle Scholar
  41. Samhan-Arias AK, Tyurina YY, Kagan VE: Lipid antioxidants: free radical scavenging versus regulation of enzymatic lipid peroxidation. J Clin Biochem Nutr. 2011, 48 (1): 91-95.PubMed CentralView ArticlePubMedGoogle Scholar
  42. Miller ER, Appel LJ, Risby TH: Effect of dietary patterns on measures of lipid peroxidation results from a randomized clinical trial. Circulation. 1998, 98: 2390-2395. 10.1161/01.CIR.98.22.2390View ArticlePubMedGoogle Scholar
  43. Birringer M: Hormetics: dietary triggers of an adaptive stress response. Pharm Res. 2011, 28 (11): 2680-94. 10.1007/s11095-011-0551-1View ArticlePubMedGoogle Scholar
  44. Li H, Lelliott C, Hakansson P, Ploj K, Tuneld A, Verolin-Johansson M, Benthem L, Carlsoon B, Storlien L: Intestinal, adipose, and liver inflammation in diet-induced obese mice. Metabolism. 2008, 57 (12): 1704-1710. 10.1016/j.metabol.2008.07.029View ArticlePubMedGoogle Scholar
  45. Yokota A, Fukiya S, Saiful Islam KBM, Ooka T, Ogura Y, Hayashi T, Hagio M, Ishizuka S: Is bile acid a determinant of the gut microbiota on a high-fat diet?. Gut Microbes. 2012, 3 (5): 455-459. 10.4161/gmic.21216View ArticlePubMedGoogle Scholar
  46. Bertol TM, Moraes N, Franke MR: Partial substitution of soybean meal by full-Fat extruded soybean in diets for weaned piglets. Rev Bra de Zootec. 2001, 30 (3): 744-752. 10.1590/S1516-35982001000300020. 10.1590/S1516-35982001000300020View ArticleGoogle Scholar
  47. Caruso M, Demonty A: Histomorphometry of the small intestine of rats submitted to different proteic sources. Alim Nutr. 2005, 16 (2): 131-136.Google Scholar
  48. Soares JL, Donzele JL, Oliveira RFM, Ferreira AS, Ferreira CLLF, Hannas MI, Apolônio LR: Whole processed (fermented and extruded) soybean and soybean meal in replacement of dried milk in diet of piglets weaned at 14 days of age. Rev Bras Zootec. 2000, 29 (4): 1153-1161. 10.1590/S1516-35982000000400028. 10.1590/S1516-35982000000400028View ArticleGoogle Scholar
  49. Machado FPP, Queiróz JH, Oliveira MGA, Piovesan ND, Peluzio MCG, Costa NMB, Moreira MA: Effects of heating on protein quality of soybean flour devoid of kunitz inhibitor and lectin. Food Chem. 2002, 107 (2): 649-655.View ArticleGoogle Scholar
  50. Pluske JR, Hampson DJ, Williams IH: Factors influencing the structure and function of the small intestine in the weaned pig: a review. Live Prod Sci. 1997, 51: 215-236. 10.1016/S0301-6226(97)00057-2. 10.1016/S0301-6226(97)00057-2View ArticleGoogle Scholar
  51. Reeves PG, Nielsen FH, Fahey GC: AIN-93 purified diets for laboratory rodents: final report of the American institute of nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr. 1993, 123: 1939-1951.PubMedGoogle Scholar
  52. Association of Official Analytical Chemists: Official methods of analysis. 1997, 2-Maryland: AOAC.Google Scholar
  53. Buege JA, Aust SD: Microsomal lipid peroxidation. Methods Enzymol. 1978, 52: 302-310.View ArticlePubMedGoogle Scholar
  54. Sabarense CM, Rocha KS, Rosa DD, Martins JH, Pereira MM, Silva FF, Steward BL: A new computational method for hepatic fat micro vesicles counting in histological study in rats. Biochem Biophys Res Commun. 2012, 418 (2): 284-289. 10.1016/j.bbrc.2012.01.011View ArticlePubMedGoogle Scholar
  55. Rosa DD, Sales RL, Moraes LFS, Lourenço FC, Neves CA, Sabarense CM, Ribeiro SMR, Peluzio MCG: Flaxseed, olive and fish oil influence plasmatic lipids, lymphocyte migration and morphometry of the intestinal of wistar rats. Acta Cir Bras. 2010, 25 (3): 275-280. 10.1590/S0102-86502010000300010View ArticlePubMedGoogle Scholar
  56. SAEG – Sistema de Análises Estatísticas e Genéticas: Desenvolvido pela equipe técnica da fundação arthur bernardes, versão 9.1. 1998, Viçosa, MG: Universidade Federal de Viçosa: Software.Google Scholar

Copyright

© Andrade et al.; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.